Cargando…

Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney

Piroxicam is used to treat the pain, swelling, and stiffness associated with osteoarthritis and rheumatoid arthritis, but it has many side effects, such as hypertension, elevation of liver enzymes, and hepatitis. This study used selenium-enriched probiotics to reduce the side effects of piroxicam on...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Ahmed Mohamed, Khattab, Abd El-Nasser A., Abd El-Razik, Khaled A., Othman, Sarah I., Allam, Ahmed A., Abu-Taweel, Gasem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462618/
https://www.ncbi.nlm.nih.gov/pubmed/36085399
http://dx.doi.org/10.1007/s10787-022-01064-1
_version_ 1784787226220036096
author Darwish, Ahmed Mohamed
Khattab, Abd El-Nasser A.
Abd El-Razik, Khaled A.
Othman, Sarah I.
Allam, Ahmed A.
Abu-Taweel, Gasem M.
author_facet Darwish, Ahmed Mohamed
Khattab, Abd El-Nasser A.
Abd El-Razik, Khaled A.
Othman, Sarah I.
Allam, Ahmed A.
Abu-Taweel, Gasem M.
author_sort Darwish, Ahmed Mohamed
collection PubMed
description Piroxicam is used to treat the pain, swelling, and stiffness associated with osteoarthritis and rheumatoid arthritis, but it has many side effects, such as hypertension, elevation of liver enzymes, and hepatitis. This study used selenium-enriched probiotics to reduce the side effects of piroxicam on the liver and kidney tissues and functions. Forty-eight male albino mice were randomly assigned to control, piroxicam (P), piroxicam plus selenium-enriched Lactobacillus plantarum PSe40/60/1 (P + SP), piroxicam plus selenium-enriched Bifidobacterium longum BSe50/20/1 (P + SB), selenium-enriched L. plantarum PSe40/60/1 (SP), and selenium-enriched B. longum BSe50/20/1 (SB) groups. In this study, the function of the liver and kidney was biochemically determined; the histopathology of the liver and kidney tissues was microscopically examined and the expression of inflammatory and anti-inflammatory genes in liver and kidney tissues was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Liver and kidney functions were significantly reduced in the piroxicam group compared with control. Liver and kidney tissues were damaged in the piroxicam group while they appeared more or less normal in the SB group. The expression of inflammatory genes was significantly up-regulated in the liver and kidney tissues of the piroxicam group compared to the control group. The expression of anti-inflammatory genes was significantly down-regulated in the liver and kidney of the piroxicam group and up-regulated in the liver and kidney of the SB group compared to the control group. Therefore, these mutated strains of probiotics were useful in reducing the side effects of the piroxicam drug on the liver and kidney.
format Online
Article
Text
id pubmed-9462618
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-94626182022-09-10 Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney Darwish, Ahmed Mohamed Khattab, Abd El-Nasser A. Abd El-Razik, Khaled A. Othman, Sarah I. Allam, Ahmed A. Abu-Taweel, Gasem M. Inflammopharmacology Original Article Piroxicam is used to treat the pain, swelling, and stiffness associated with osteoarthritis and rheumatoid arthritis, but it has many side effects, such as hypertension, elevation of liver enzymes, and hepatitis. This study used selenium-enriched probiotics to reduce the side effects of piroxicam on the liver and kidney tissues and functions. Forty-eight male albino mice were randomly assigned to control, piroxicam (P), piroxicam plus selenium-enriched Lactobacillus plantarum PSe40/60/1 (P + SP), piroxicam plus selenium-enriched Bifidobacterium longum BSe50/20/1 (P + SB), selenium-enriched L. plantarum PSe40/60/1 (SP), and selenium-enriched B. longum BSe50/20/1 (SB) groups. In this study, the function of the liver and kidney was biochemically determined; the histopathology of the liver and kidney tissues was microscopically examined and the expression of inflammatory and anti-inflammatory genes in liver and kidney tissues was determined by quantitative real-time polymerase chain reaction (qRT-PCR). Liver and kidney functions were significantly reduced in the piroxicam group compared with control. Liver and kidney tissues were damaged in the piroxicam group while they appeared more or less normal in the SB group. The expression of inflammatory genes was significantly up-regulated in the liver and kidney tissues of the piroxicam group compared to the control group. The expression of anti-inflammatory genes was significantly down-regulated in the liver and kidney of the piroxicam group and up-regulated in the liver and kidney of the SB group compared to the control group. Therefore, these mutated strains of probiotics were useful in reducing the side effects of the piroxicam drug on the liver and kidney. Springer International Publishing 2022-09-09 2022 /pmc/articles/PMC9462618/ /pubmed/36085399 http://dx.doi.org/10.1007/s10787-022-01064-1 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Darwish, Ahmed Mohamed
Khattab, Abd El-Nasser A.
Abd El-Razik, Khaled A.
Othman, Sarah I.
Allam, Ahmed A.
Abu-Taweel, Gasem M.
Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title_full Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title_fullStr Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title_full_unstemmed Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title_short Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
title_sort effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462618/
https://www.ncbi.nlm.nih.gov/pubmed/36085399
http://dx.doi.org/10.1007/s10787-022-01064-1
work_keys_str_mv AT darwishahmedmohamed effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney
AT khattababdelnassera effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney
AT abdelrazikkhaleda effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney
AT othmansarahi effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney
AT allamahmeda effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney
AT abutaweelgasemm effectivenessofnewseleniumenrichedmutatedprobioticsinreducinginflammatoryeffectsofpiroxicammedicationinliverandkidney